Literature DB >> 18849360

Ligand selectivity of D2 dopamine receptors is modulated by changes in local dynamics produced by sodium binding.

Spencer S Ericksen1, David F Cummings, Harel Weinstein, John A Schetz.   

Abstract

We have uncovered a significant allosteric response of the D(2) dopamine receptor to physiologically relevant concentrations of sodium (140 mM), characterized by a sodium-enhanced binding affinity for a D(4)-selective class of agonists and antagonists. This enhancement is significantly more pronounced in a D(2)-V2.61(91)F mutant and cannot be mimicked by an equivalent concentration of the sodium replacement cation N-methyl-D-glucamine. This phenomenon was explored computationally at the molecular level by analyzing the effect of sodium binding on the dynamic properties of D(2) receptor model constructs. Normal mode analysis identified one mode (M(19)), which is involved in the open/closed motions of the binding cleft as being particularly sensitive to the sodium effect. To examine the consequences for D(2) receptor ligand recognition, one of the ligands, L-745,870 [3-{[4-(4-chlorophenyl) piperazin-1-yl]-methyl}-1H-pyrrolo[2,3-b]pyridine or CPPMA, chlorophenylpiperazinyl methylazaindole], was docked into conformers along the M(19) trajectory. Structurally and pharmacologically well established ligand-receptor interactions, including the ionic interaction with D3.32(114) and interactions between the ligand aryl moieties and V2.61(91)F, were achieved only in "open" phase conformers. The docking of (-)-raclopride [3,5-dichloro-N-(1-ethylpyrrolidin-2-ylmethyl)-2-hydroxy-6-methoxybenzamide] suggests that the same binding cleft changes in response to sodium-binding perturbation account as well for the enhancements in binding affinity for substituted benzamides in the wild-type D(2) receptor. Our findings demonstrate how key interactions can be modulated by occupancy at an allosteric site and are consistent with a mechanism in which sodium binding enhances the affinity of selected ligands through dynamic changes that increase accessibility of substituted benzamides and 1,4-DAP ligands to the orthosteric site and accessibility of 1,4-DAPs to V2.61(91)F.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18849360      PMCID: PMC2685898          DOI: 10.1124/jpet.108.141531

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  32 in total

1.  Large Amplitude Elastic Motions in Proteins from a Single-Parameter, Atomic Analysis.

Authors: 
Journal:  Phys Rev Lett       Date:  1996-08-26       Impact factor: 9.161

2.  Nonconserved residues in the second transmembrane-spanning domain of the D(4) dopamine receptor are molecular determinants of D(4)-selective pharmacology.

Authors:  J A Schetz; P S Benjamin; D R Sibley
Journal:  Mol Pharmacol       Date:  2000-01       Impact factor: 4.436

3.  Allostery without conformational change. A plausible model.

Authors:  A Cooper; D T Dryden
Journal:  Eur Biophys J       Date:  1984       Impact factor: 1.733

Review 4.  Dopamine receptor microdomains involved in molecular recognition and the regulation of drug affinity and function.

Authors:  Christina Z Floresca; John A Schetz
Journal:  J Recept Signal Transduct Res       Date:  2004-08       Impact factor: 2.092

5.  Interactions of full and partial agonists with HT29 cell alpha 2-adrenoceptor: comparative study of [3H]UK-14,304 and [3H]clonidine binding.

Authors:  H Paris; J Galitzky; J M Senard
Journal:  Mol Pharmacol       Date:  1989-03       Impact factor: 4.436

6.  Structural determinants of pharmacological specificity between D(1) and D(2) dopamine receptors.

Authors:  Hongxiang Lan; Curtiss J Durand; Martha M Teeter; Kim A Neve
Journal:  Mol Pharmacol       Date:  2005-10-19       Impact factor: 4.436

7.  Mutation of an aspartate residue highly conserved among G-protein-coupled receptors results in nonreciprocal disruption of alpha 2-adrenergic receptor-G-protein interactions. A negative charge at amino acid residue 79 forecasts alpha 2A-adrenergic receptor sensitivity to allosteric modulation by monovalent cations and fully effective receptor/G-protein coupling.

Authors:  B P Ceresa; L E Limbird
Journal:  J Biol Chem       Date:  1994-11-25       Impact factor: 5.157

8.  Certain 1,4-disubstituted aromatic piperidines and piperazines with extreme selectivity for the dopamine D4 receptor interact with a common receptor microdomain.

Authors:  Sandhya Kortagere; Peter Gmeiner; Harel Weinstein; John A Schetz
Journal:  Mol Pharmacol       Date:  2004-09-24       Impact factor: 4.436

9.  Refinement of docked protein-ligand and protein-DNA structures using low frequency normal mode amplitude optimization.

Authors:  Erik Lindahl; Marc Delarue
Journal:  Nucleic Acids Res       Date:  2005-08-08       Impact factor: 16.971

10.  NOMAD-Ref: visualization, deformation and refinement of macromolecular structures based on all-atom normal mode analysis.

Authors:  Erik Lindahl; Cyril Azuara; Patrice Koehl; Marc Delarue
Journal:  Nucleic Acids Res       Date:  2006-07-01       Impact factor: 16.971

View more
  15 in total

1.  Design, synthesis, radiolabeling, and in vivo evaluation of carbon-11 labeled N-[2-[4-(3-cyanopyridin-2-yl)piperazin-1-yl]ethyl]-3-methoxybenzamide, a potential positron emission tomography tracer for the dopamine D(4) receptors.

Authors:  Enza Lacivita; Paola De Giorgio; Irene T Lee; Sean I Rodeheaver; Bryan A Weiss; Claudia Fracasso; Silvio Caccia; Francesco Berardi; Roberto Perrone; Ming-Rong Zhang; Jun Maeda; Makoto Higuchi; Tetsuya Suhara; John A Schetz; Marcello Leopoldo
Journal:  J Med Chem       Date:  2010-10-28       Impact factor: 7.446

Review 2.  Modulation of GPCRs by monovalent cations and anions.

Authors:  Andrea Strasser; Hans-Joachim Wittmann; Erich H Schneider; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-11-30       Impact factor: 3.000

3.  Synthesis and structure-affinity relationships of novel small molecule natural product derivatives capable of discriminating between serotonin 5-HT1A, 5-HT2A, 5-HT2C receptor subtypes.

Authors:  David F Cummings; Diana C Canseco; Pratikkumar Sheth; James E Johnson; John A Schetz
Journal:  Bioorg Med Chem       Date:  2010-05-15       Impact factor: 3.641

4.  Transmembrane segment five serines of the D4 dopamine receptor uniquely influence the interactions of dopamine, norepinephrine, and Ro10-4548.

Authors:  David F Cummings; Spencer S Ericksen; Angela Goetz; John A Schetz
Journal:  J Pharmacol Exp Ther       Date:  2010-03-09       Impact factor: 4.030

Review 5.  Diversity and modularity of G protein-coupled receptor structures.

Authors:  Vsevolod Katritch; Vadim Cherezov; Raymond C Stevens
Journal:  Trends Pharmacol Sci       Date:  2011-10-25       Impact factor: 14.819

6.  Structural basis for Na(+)-sensitivity in dopamine D2 and D3 receptors.

Authors:  Mayako Michino; R Benjamin Free; Trevor B Doyle; David R Sibley; Lei Shi
Journal:  Chem Commun (Camb)       Date:  2015-05-21       Impact factor: 6.222

7.  Sodium binding to hH3R and hH 4R--a molecular modeling study.

Authors:  Hans-Joachim Wittmann; Roland Seifert; Andrea Strasser
Journal:  J Mol Model       Date:  2014-08-07       Impact factor: 1.810

8.  Induced effects of sodium ions on dopaminergic G-protein coupled receptors.

Authors:  Jana Selent; Ferran Sanz; Manuel Pastor; Gianni De Fabritiis
Journal:  PLoS Comput Biol       Date:  2010-08-12       Impact factor: 4.475

9.  The HIV antiretroviral drug efavirenz has LSD-like properties.

Authors:  Michael B Gatch; Alexey Kozlenkov; Ren-Qi Huang; Wenjuan Yang; Jacques D Nguyen; Javier González-Maeso; Kenner C Rice; Charles P France; Glenn H Dillon; Michael J Forster; John A Schetz
Journal:  Neuropsychopharmacology       Date:  2013-05-24       Impact factor: 7.853

10.  Three amino acids in the D2 dopamine receptor regulate selective ligand function and affinity.

Authors:  David F Cummings; Spencer S Ericksen; John A Schetz
Journal:  J Neurochem       Date:  2009-04-16       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.